RT Journal Article T1 Effects of copy number variations on brain structure and risk for psychiatric illness: Large-scale studies from the ENIGMA working groups on CNVs. A1 Sønderby, Ida E A1 Ching, Christopher R K A1 Thomopoulos, Sophia I A1 van der Meer, Dennis A1 Sun, Daqiang A1 Villalon-Reina, Julio E A1 Agartz, Ingrid A1 Amunts, Katrin A1 Arango, Celso A1 Armstrong, Nicola J A1 Ayesa-Arriola, Rosa A1 Bakker, Geor A1 Bassett, Anne S A1 Boomsma, Dorret I A1 Bülow, Robin A1 Butcher, Nancy J A1 Calhoun, Vince D A1 Caspers, Svenja A1 Chow, Eva W C A1 Cichon, Sven A1 Ciufolini, Simone A1 Craig, Michael C A1 Crespo-Facorro, Benedicto A1 Cunningham, Adam C A1 Dale, Anders M A1 Dazzan, Paola A1 de Zubicaray, Greig I A1 Djurovic, Srdjan A1 Doherty, Joanne L A1 Donohoe, Gary A1 Draganski, Bogdan A1 Durdle, Courtney A A1 Ehrlich, Stefan A1 Emanuel, Beverly S A1 Espeseth, Thomas A1 Fisher, Simon E A1 Ge, Tian A1 Glahn, David C A1 Grabe, Hans J A1 Gur, Raquel E A1 Gutman, Boris A A1 Haavik, Jan A1 Håberg, Asta K A1 Hansen, Laura A A1 Hashimoto, Ryota A1 Hibar, Derrek P A1 Holmes, Avram J A1 Hottenga, Jouke-Jan A1 Hulshoff Pol, Hilleke E A1 Jalbrzikowski, Maria A1 Knowles, Emma E M A1 Kushan, Leila A1 Linden, David E J A1 Liu, Jingyu A1 Lundervold, Astri J A1 Martin-Brevet, Sandra A1 Martínez, Kenia A1 Mather, Karen A A1 Mathias, Samuel R A1 McDonald-McGinn, Donna M A1 McRae, Allan F A1 Medland, Sarah E A1 Moberget, Torgeir A1 Modenato, Claudia A1 Monereo Sánchez, Jennifer A1 Moreau, Clara A A1 Mühleisen, Thomas W A1 Paus, Tomas A1 Pausova, Zdenka A1 Prieto, Carlos A1 Ragothaman, Anjanibhargavi A1 Reinbold, Céline S A1 Reis Marques, Tiago A1 Repetto, Gabriela M A1 Reymond, Alexandre A1 Roalf, David R A1 Rodriguez-Herreros, Borja A1 Rucker, James J A1 Sachdev, Perminder S A1 Schmitt, James E A1 Schofield, Peter R A1 Silva, Ana I A1 Stefansson, Hreinn A1 Stein, Dan J A1 Tamnes, Christian K A1 Tordesillas-Gutiérrez, Diana A1 Ulfarsson, Magnus O A1 Vajdi, Ariana A1 van 't Ent, Dennis A1 van den Bree, Marianne B M A1 Vassos, Evangelos A1 Vázquez-Bourgon, Javier A1 Vila-Rodriguez, Fidel A1 Walters, G Bragi A1 Wen, Wei A1 Westlye, Lars T A1 Wittfeld, Katharina A1 Zackai, Elaine H A1 Stefánsson, Kári A1 Jacquemont, Sebastien A1 Thompson, Paul M A1 Bearden, Carrie E A1 Andreassen, Ole A A1 ENIGMA-CNV Working Group, A1 ENIGMA 22q11.2 Deletion Syndrome Working Group, K1 brain structural imaging K1 copy number variant K1 diffusion tensor imaging K1 evolution K1 genetics-first approach K1 neurodevelopmental disorders K1 psychiatric disorders AB The Enhancing NeuroImaging Genetics through Meta-Analysis copy number variant (ENIGMA-CNV) and 22q11.2 Deletion Syndrome Working Groups (22q-ENIGMA WGs) were created to gain insight into the involvement of genetic factors in human brain development and related cognitive, psychiatric and behavioral manifestations. To that end, the ENIGMA-CNV WG has collated CNV and magnetic resonance imaging (MRI) data from ~49,000 individuals across 38 global research sites, yielding one of the largest studies to date on the effects of CNVs on brain structures in the general population. The 22q-ENIGMA WG includes 12 international research centers that assessed over 533 individuals with a confirmed 22q11.2 deletion syndrome, 40 with 22q11.2 duplications, and 333 typically developing controls, creating the largest-ever 22q11.2 CNV neuroimaging data set. In this review, we outline the ENIGMA infrastructure and procedures for multi-site analysis of CNVs and MRI data. So far, ENIGMA has identified effects of the 22q11.2, 16p11.2 distal, 15q11.2, and 1q21.1 distal CNVs on subcortical and cortical brain structures. Each CNV is associated with differences in cognitive, neurodevelopmental and neuropsychiatric traits, with characteristic patterns of brain structural abnormalities. Evidence of gene-dosage effects on distinct brain regions also emerged, providing further insight into genotype-phenotype relationships. Taken together, these results offer a more comprehensive picture of molecular mechanisms involved in typical and atypical brain development. This "genotype-first" approach also contributes to our understanding of the etiopathogenesis of brain disorders. Finally, we outline future directions to better understand effects of CNVs on brain structure and behavior. YR 2021 FD 2021-02-21 LK http://hdl.handle.net/10668/17215 UL http://hdl.handle.net/10668/17215 LA en DS RISalud RD Apr 11, 2025